Digital health companies need GTM strategies that understand clinical workflows, regulatory requirements, and healthcare buying committees. Traditional tech GTM approaches fail in healthcare markets where trust and clinical evidence drive adoption decisions.
The Problem
Clinical adoption cycles are fundamentally different
Healthcare organizations move extremely slowly when adopting new technology. Clinical workflows are deeply embedded, change management requires extensive training, and any disruption can impact patient care. Most digital health companies build GTM strategies around typical SaaS adoption timelines that completely underestimate healthcare change management requirements. The result is frustrated sales cycles, pilot programs that never expand, and technology that sits unused despite proven clinical value.
Multiple stakeholder approval creates complex sales
Healthcare technology purchases require approval from clinical staff, administrators, IT security, legal compliance, and often board-level executives. Each stakeholder group has different evaluation criteria, concerns, and decision-making timelines. Most digital health GTM strategies focus on single decision makers and fail to address the full buying committee's needs, creating stakeholder alignment problems that kill deals even when clinical value is proven.
Clinical evidence requirements aren't built into GTM
Healthcare buyers demand clinical evidence, peer validation, and outcome data before considering technology adoption. They need proof that solutions improve patient outcomes, don't create safety risks, and integrate with existing clinical workflows. Most digital health companies treat clinical evidence as a nice-to-have rather than a foundational GTM requirement, leaving sales teams without the proof points necessary to drive healthcare purchasing decisions.
Regulatory and compliance complexity slows everything
Healthcare technology purchases involve complex regulatory considerations — HIPAA compliance, FDA classifications, data governance requirements, security standards, and often state-specific regulations. Legal and compliance review processes can take months and kill deals if not managed properly. Most GTM strategies underestimate regulatory complexity and fail to build compliance considerations into sales processes from the beginning.
How We Help
We begin with comprehensive healthcare market analysis specific to your clinical domain and target stakeholders. This involves understanding clinical adoption patterns, healthcare buying committee dynamics, regulatory requirements, and competitive landscape analysis. We map the complete healthcare sales ecosystem including clinical champions, administrative decision makers, IT gatekeepers, and compliance stakeholders to build realistic GTM timelines and strategies.
Our strategy development creates healthcare-specific GTM approaches that account for clinical adoption timelines, regulatory requirements, and multi-stakeholder sales processes. We design pilot program frameworks, clinical evidence development plans, and stakeholder engagement strategies that build momentum through healthcare organizations systematically. The key is understanding that healthcare GTM requires relationship building, not just product demonstrations.
Implementation involves building healthcare sales processes, clinical champion development programs, and evidence generation systems that support long-term healthcare market penetration. We help establish clinical advisory boards, pilot program structures, and customer success frameworks that turn early adopters into advocates and reference customers for broader market expansion.
Ongoing optimization includes clinical outcome measurement, healthcare customer success tracking, and regulatory landscape monitoring that ensures GTM strategies remain effective as healthcare markets evolve. We implement feedback systems that capture clinical adoption insights and competitive intelligence to continuously refine healthcare market approach and positioning.
What we deliver
- Healthcare market analysis and clinical adoption strategy
- Multi-stakeholder GTM framework with regulatory planning
- Clinical evidence development and pilot program design
- Healthcare sales process and champion development system
- Customer success measurement and market expansion strategy
Digital health GTM success requires clinical champions who become internal advocates for your solution. The companies that scale in healthcare markets are those that build GTM strategies around clinician relationships and clinical evidence development, not traditional sales and marketing tactics.
Our Methodology
Our 90-day approach starts with deep healthcare market research to understand clinical adoption patterns, stakeholder dynamics, and competitive positioning in your target healthcare segments. We analyze successful digital health launches and failed market entries to identify critical success factors specific to your clinical domain. Days 1-30 focus on healthcare market understanding and strategic planning.
Days 31-60 involve building healthcare-specific GTM infrastructure including clinical pilot frameworks, evidence development systems, and stakeholder engagement processes. We create healthcare sales tools, clinical communication materials, and regulatory documentation that support complex healthcare sales cycles. This phase focuses on building scalable healthcare market entry systems.
The final 30 days concentrate on launch execution, measurement systems, and optimization frameworks. We implement clinical outcome tracking, healthcare customer feedback systems, and competitive monitoring that ensures GTM effectiveness in healthcare markets. We establish continuous improvement processes that adapt to healthcare market feedback and regulatory changes.
How We Work
We start with a comprehensive 2-week healthcare market assessment, analyzing your current clinical relationships, regulatory positioning, and healthcare competitive landscape. Week 3-4 involve GTM strategy development and healthcare implementation planning.
Our team includes a healthcare GTM strategist with clinical market experience, a regulatory specialist who understands healthcare compliance requirements, and a clinical adoption expert who knows healthcare change management. From your side, we need access to clinical customers, healthcare sales data, and any existing clinical evidence or pilot program results.
We operate on monthly GTM reviews with bi-weekly implementation check-ins. You'll receive detailed healthcare market analysis, clinical adoption metrics, and strategic recommendations monthly. Most digital health companies see improved clinical stakeholder engagement within 8-10 weeks and enhanced healthcare sales effectiveness within 12-16 weeks. Initial engagements typically run 4-6 months.
- Accelerated clinical adoption and stakeholder alignment
- Improved healthcare sales cycle effectiveness and win rates
- Enhanced clinical evidence development and reference building
- Scalable healthcare GTM systems and market expansion
If your digital health company needs go-to-market leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
How much does a GTM strategy engagement cost for digital health companies?
Our digital health GTM engagements typically range from $25K-40K per month, depending on clinical complexity and market scope. This covers healthcare strategy development, clinical adoption planning, and regulatory GTM support. Compared to hiring a healthcare GTM leader with clinical experience ($200K+ salary), you're getting specialized expertise immediately. Most companies see improved healthcare sales effectiveness within 90-120 days.
How long before we see results from a healthcare GTM engagement?
You'll see improvements in clinical stakeholder engagement and sales process effectiveness within 8-10 weeks as healthcare-specific GTM systems get implemented. Enhanced clinical adoption rates and healthcare win rates typically appear within 12-16 weeks. Healthcare markets move slowly, so full GTM impact measurement takes 6-9 months, but leading indicators improve much faster.
How does the GTM team integrate with our existing healthcare sales staff?
We work directly with your healthcare sales, clinical affairs, and customer success teams through regular strategy sessions and implementation support. Our recommendations integrate with existing clinical communication processes while optimizing for healthcare-specific adoption challenges. We provide detailed training on healthcare selling and clinical stakeholder management.
What makes Winston Francois different from traditional healthcare consulting firms?
Traditional healthcare consultants often focus on clinical operations or generic healthcare strategy without understanding digital health GTM dynamics. We specialize in technology GTM within healthcare markets, with deep experience in clinical adoption, healthcare stakeholder management, and regulatory GTM planning. We build strategies around clinical evidence and relationship development, not generic sales processes.
How do you measure ROI from a healthcare GTM engagement?
We track clinical adoption rates, healthcare sales cycle effectiveness, and stakeholder engagement metrics as primary success indicators. We also monitor clinical evidence development, reference customer acquisition, and regulatory milestone achievement. The goal is sustainable improvements in healthcare market penetration and clinical adoption, not just short-term sales increases. Most companies see positive healthcare GTM impact within 90-120 days.
What type of digital health company is the right fit for this service?
We work best with digital health companies that have proven clinical value but struggle with healthcare market adoption and sales cycle effectiveness. Typically Series A-B companies with $5M-40M ARR who need to scale clinical adoption beyond early pilots. The first step is analyzing your current healthcare sales performance and clinical adoption patterns to identify GTM optimization opportunities.
